Baidu
map

重磅!2017年度国家科学技术奖受理项目公示!(共862项,附生物医药领域名单)

2017-03-13 佚名 生物探索

2017年度国家科学技术奖推荐工作已经结束。国家科学技术奖励工作办公室发布公告称,形式审查合格的2017年度国家自然科学奖项目共205项,技术发明奖通用项目共197项,科学技术进步奖通用项目共460项。


3月10日,国家科学技术奖励工作办公室发布公告称,2017年度国家科学技术奖推荐工作已经结束。根据《国家科学技术奖励条例实施细则》的规定,现将形式审查合格的2017年度国家自然科学奖项目205项,技术发明奖通用项目197项以及科学技术进步奖通用项目460项进行公示。专用项目在适当范围内公示。相关:中华医学会公示2017国家科学技术奖励项目

2017年度国家自然科学奖受理项目共分为10个组,包括数学组(12项)、物理与天文学组(10项)、化学组(29项)、地球科学组(30项)、生物学组(18项)、基础医学组(20项)、信息科学组(30项)、材料科学组(23项)、工程技术科学组(25项)以及力学组(8项)。以下是生物学组和基础医学组通过审查的项目:

国家自然科学奖--生物学组


国家自然科学奖--基础医学组


2017年度国家技术发明奖受理项目(通用项目)也分为10组,包括农林养殖组(14项)、医药卫生组(9项)、国土资源组(14项)、环境与水利组(20项)、轻工纺织组(11项)、化工组(14项)、材料与冶金组(31项)、机械与动力组(33项)、电子信息组(36项)以及工程建设组(15项)。以下是医药卫生组获受理项目:

国家技术发明奖--医药卫生组


2017年度国家科学技术进步奖受理项目(通用项目)分为30组,共460项;以下是内科与预防医学组(28项)、中医中药组(16项)、药物与生物医学工程组(14项)、外科与耳鼻咽喉颌组(24项)获受理的项目:

国家科技进步奖--内科与预防医学组


国家科技进步奖--中医中药组


国家科技进步奖--药物与生物医学工程组


国家科技进步奖--外科与耳鼻咽喉颌组


《国家科学技术奖励工作办公室公告第86号》指出,自受理项目公示之日起40日内,任何单位或者个人对公示项目的创新性、先进性、实用性及推荐材料真实性和项目主要完成人、主要完成单位持有异议的,应当以书面方式向我办提出,并提供必要的证明材料。超出期限的异议不予受理。

备注:本文整理自国家科学技术奖励工作办公室官网,获受理项目具体介绍点击【国家科学技术奖励工作办公室公告第86号】阅读。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2018-05-15 wangjianli2934

    这么多高手.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-15 cathymary
  6. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-15 xxxx1054
  7. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-15 明天会更好!

    学习了,很棒的!!!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=315366, encodeId=b1bb31536642, content=这么多高手., beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d7e2114920, createdName=wangjianli2934, createdTime=Tue May 15 14:13:27 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049693, encodeId=a54e2049693c3, content=<a href='/topic/show?id=f2aae4867ba' target=_blank style='color:#2F92EE;'>#科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74867, encryptionId=f2aae4867ba, topicName=科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Fri Jul 21 14:00:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928380, encodeId=c08819283802b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Fri Apr 21 04:00:00 CST 2017, time=2017-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933302, encodeId=da9a1933302dc, content=<a href='/topic/show?id=7b49409266e' target=_blank style='color:#2F92EE;'>#国家科学技术奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40926, encryptionId=7b49409266e, topicName=国家科学技术奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Fri Sep 22 12:00:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408854, encodeId=31251408854b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549066, encodeId=9011154906630, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Mar 15 02:00:00 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179915, encodeId=52421e99159e, content=学习了,很棒的!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Wed Mar 15 00:03:12 CST 2017, time=2017-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179565, encodeId=b6281e956501, content=签到学习了很多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Mon Mar 13 11:57:58 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-13 Chongyang Zhang

    签到学习了很多。

    0

相关资讯

遏制医患冲突,就差国防部?——2016年医患关系大盘点

岁末,又到了盘点的时候。我们来聊聊2016年的医患关系形势。 病,依然重      这个社会中,很难做到“客观”。评价危重病人的病情,也是如此,要看是说给谁听。有时候,为了避免对病人造成心理打击、营造和谐的治疗氛围,需要编瞎话。      我估计,按照往年的路数,明年年初有关部门在总结2016年医患关系形

北京四环房价每平3千元的那年跨年,这个时代在干些什么?你呢?

长风从漆黑的苍穹中扑下,四环外荒草折腰,几个均价不到3000元每平的新楼盘内,灯光稀稀落落。

2017年中国大学科技创新竞争力排行榜300强

2017年1月,中国科学评价研究中心(RCCSE)、武汉大学中国教育质量评价中心(ECCEQ)和中国科教评价网(www.nseac.com)联合发布《中国大学及学科专业评价报告(2017-2018)》,发布了973所本科院校的科技创新竞争力排行榜。

2017中国医药类大学排行榜,你学校排名第几?

在最新艾瑞深中国校友会网2017中国大学综合实力排行榜700强中,北京协和医学院雄居2017中国医药类大学排行榜榜首,首都医科大学第2,南方医科大学第3,天津医科大学第4,中国药科大学第5,北京中医药大学第6,哈尔滨医科大学第7,南京医科大学第8,中国医科大学第9,上海中医药大学第10。

2017有望上市的15种重磅药物

2017年将有众多新药被制药和生物技术公司推向市场,其中不乏年销售额可超过10亿美元的重磅药物(Blockbuster Drug)。日前,Endpoint News推出了它们预测的将于2017年上市的15种重磅药物。

2017年将影响每个医护人员的几件事

2017年卫生计生科教工作的总体要求是:全面贯彻党的十八大和十八届三中、四中、五中、六中全会精神,全面贯彻习近平总书记系列重要讲话精神,全面贯彻全国卫生与健康大会、全国科技创新大会、2017年全国卫生计生工作会议精神,以改革创新为动力,以提升科技发展和人才保障能力为主线,以狠抓落实为核心,深化科技体制改革,加快创新体系建设,推进重大项目实施,落实住院医师规范化培训制度,强化全科医生培养,加强生

Baidu
map
Baidu
map
Baidu
map